Rajiv Patni
CIK 1616200 · EVP, Chief R&D Officer · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
19
Lifetime Open-Market Net
-$64.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BTAI | Director | — | $1.14 | — | $0 | 2 | 2026-01-12 |
| QNCX | Director | — | $0.93 | — | $0 | 3 | 2025-06-06 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | EVP, Chief R&D Officer | 0 | $172.36 | $0 | $0 | 2 | 2023-09-26 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP, CMO | 35,000 | — | — | $0 | 2 | 2020-07-02 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Chief Medical Officer | 49,141 | $8.22 | $403.9K | -$64.0K | 8 | 2019-04-10 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-21 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −2,374 | -$19.0K | EDGAR |
| 2018-03-22 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −1,252 | -$32.5K | EDGAR |
| 2018-03-09 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +9,125 | $0 | EDGAR |
| 2017-03-22 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −733 | -$12.5K | EDGAR |
| 2017-01-20 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +6,875 | $0 | EDGAR |
| 2016-03-08 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +7,500 | $102.5K | EDGAR |
| 2015-06-09 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-07 | — | Buy (P) | +5,050 | $20.0K | |
| 2014-09-02 | — | Grant (A) | — | $0 |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.